IDiyas

For the Inventor, By the Inventor

Westfield, NJ, United States of America

Douglas J MacNeil

USPTO Granted Patents = 15 

Average Co-Inventor Count = 3.7

ph-index = 6

Forward Citations = 155(Granted Patents)


Company Filing History:

goldMedal12 out of 4,770 
 
Merck + Co., Inc.
 patents
silverMedal3 out of 832,680 
Other
 patents

Years Active: 1993-2007

Loading Chart...
15 patents (USPTO):
1. 7179886 - Cloning and identification of the motilin receptor (2007-02-20),
2. 7029865 - DNA molecules encoding the melanocortin 4 receptor protein from rhesus monkey (2006-04-18),
3. 6693184 - DNA molecules encoding splice variants of the human melanocortin 1 receptor protein (2004-02-17),
4. 6638942 - Spiro-indolines as Y5 receptor antagonists (2003-10-28),
5. 6573070 - DNA molecules encoding the melanocortin 4 receptor protein from rhesus monkey (2003-06-03),
6. 6495559 - NPY Y5 receptor antagonists (2002-12-17),
7. 6313298 - Spiro-indolines as Y5 receptor antagonists (2001-11-06),
8. 6191160 - Spiro-indolines as Y5 receptor antagonists (2001-02-20),
9. 6001970 - Modified human neuropeptide Y1 Receptors (1999-12-14),
10. 5939263 - Neuropeptide Y receptor (1999-08-17),
11. 5908830 - Combination therapy for the treatment of diabetes and obesity (1999-06-01),
12. 5621079 - Neuropeptide Y receptor (1997-04-15),
13. 5312753 - Strain of streptomyces avermitilis capable of glycosylating avermectin (1994-05-17),
14. 5252474 - Cloning genes from Streptomyces avermitilis for avermectin biosynthesis (1993-10-12),
15. 5194387 - Process for the incorporation of DNA molecules into microorganisms with (1993-03-16),

Title: The Innovative Contributions of Douglas J MacNeil

Introduction

Douglas J MacNeil is a prominent inventor based in Westfield, NJ (US), known for his significant contributions to the field of biotechnology. With a total of 15 patents to his name, MacNeil has made remarkable advancements in understanding and manipulating biological receptors.

Latest Patents

Among his latest patents is the cloning and identification of the motilin receptor. This invention involves the isolation and cloning of the motilin receptor, providing nucleic acid sequences and identifying two splice variants. The assays for motilin receptor ligands included in this patent may be utilized to screen and identify compounds that bind to the receptor, which can be beneficial for various gastric conditions, including gastric motility disorders. Another notable patent involves DNA molecules encoding the melanocortin 4 receptor protein from the rhesus monkey. This invention encompasses recombinant vectors, host cells, and methods for identifying selective agonists and antagonists of the rhesus MC-4R protein.

Career Highlights

Throughout his career, Douglas J MacNeil has worked with esteemed organizations, including Merck & Company, Inc. His work has significantly impacted the field of receptor biology and therapeutic development.

Collaborations

MacNeil has collaborated with notable colleagues such as Margaret A Cascieri and Ying-Duo Gao, contributing to the advancement of research in his field.

Conclusion

Douglas J MacNeil's innovative work and numerous patents highlight his vital role in biotechnology and receptor research. His contributions continue to pave the way for advancements in medical science and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…